Source: Equities

BioSculpture Technology: Biosculpture Technology, Inc. Files SEC Form 1-A/A, Offering Statement [Regulation A] (Jul. 1, 2016)

By a News Reporter-Staff News Editor at Health & Medicine Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Biosculpture Technology, Inc. (Form 1-A/A) was

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Robert L. Cucin

CEO Approval Rating

70/100

Read more